Bausch Health Companies Inc. (TSX:BHC)
Canada · Delayed Price · Currency is CAD 7.92
0.00 (0.00%)
Sep 18, 2026, 4:00 PM EST
Bausch Health Companies Ratios and Metrics
Market cap in millions CAD. Fiscal year is January - December.
Millions CAD. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 18, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 2,971 | 3,531 | 4,265 | 3,868 | 3,076 | 12,555 | |
Market Cap Growth | -14.51% | -17.22% | 10.28% | 25.76% | -75.50% | 33.42% |
Enterprise Value | 30,880 | 31,851 | 35,517 | 33,734 | 32,427 | 40,063 |
Last Close Price | 7.92 | 9.53 | 11.62 | 10.63 | 8.50 | 34.94 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 18, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | - | 16.40 | - | - | - | - |
PS Ratio | 0.19 | 0.25 | 0.31 | 0.33 | 0.28 | 1.18 |
PB Ratio | -2.61 | 6.83 | -9.21 | -35.72 | 8.74 | -291.80 |
P/FCF Ratio | 1.46 | 2.57 | 2.35 | 3.59 | - | 8.57 |
P/OCF Ratio | 1.16 | 1.84 | 1.86 | 2.84 | - | 6.96 |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 18, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 2.03 | 2.26 | 2.57 | 2.92 | 2.95 | 3.75 |
EV/EBITDA Ratio | 5.49 | 6.83 | 7.86 | 8.85 | 8.32 | 9.71 |
EV/EBIT Ratio | 8.06 | 10.60 | 13.17 | 15.76 | 16.15 | 18.54 |
EV/FCF Ratio | 15.20 | 23.16 | 19.59 | 31.27 | - | 27.36 |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 18, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | -25.91 | 55.91 | -67.82 | -275.57 | 80.77 | -674.06 |
Debt / EBITDA Ratio | 5.18 | 6.02 | 6.75 | 7.62 | 7.11 | 6.86 |
Debt / FCF Ratio | 14.52 | 21.02 | 17.33 | 27.66 | - | 19.81 |
Net Debt / Equity Ratio | -23.63 | 52.44 | -64.15 | -264.02 | 78.60 | -656.94 |
Net Debt / EBITDA Ratio | 4.85 | 5.82 | 6.58 | 7.50 | 7.10 | 6.85 |
Net Debt / FCF Ratio | 13.25 | 19.71 | 16.40 | 26.50 | -21.60 | 19.31 |
Asset Turnover | 0.42 | 0.39 | 0.36 | 0.33 | 0.30 | 0.28 |
Inventory Turnover | 1.88 | 1.87 | 1.77 | 1.94 | 2.27 | 2.29 |
Quick Ratio | 0.90 | 0.88 | 0.49 | 0.69 | 0.60 | 0.45 |
Current Ratio | 1.44 | 1.47 | 0.86 | 1.30 | 1.08 | 1.08 |
Return on Equity (ROE) | - | 436.36% | - | -686.52% | -187.61% | -328.20% |
Return on Assets (ROA) | 6.57% | 5.18% | 4.35% | 3.82% | 3.38% | 3.54% |
Return on Invested Capital (ROIC) | 13.61% | 3.59% | -3.77% | 7.41% | 6.64% | 7.09% |
Return on Capital Employed (ROCE) | 13.50% | 9.90% | 9.50% | 7.00% | 6.80% | 7.10% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 18, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | -52.49% | 6.10% | -1.55% | -20.21% | -9.90% | -9.55% |
FCF Yield | 68.41% | 38.95% | 42.50% | 27.89% | -41.63% | 11.66% |
Buyback Yield / Dilution | -0.45% | -1.90% | -0.85% | -0.80% | -0.86% | -1.10% |